logo
Select company
Select metric
$ 0Net Cash Flow - Investment Acquisitions and Disposals
VS
Market
30
Sector
26
Industry
24
History
-
$ 7.33Close
$ 3.43 - $ 14.41 52-Week Range
Ticker Information

Ticker

NAGE

Company Name

NIAGEN BIOSCIENCE INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

NIAGEN BIOSCIENCE INC - Net Cash Flow - Investment Acquisitions and Disposals Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NAGE - CF - Investments Historical data
DateNet Cash Flow - Investment Acquisitions and Disposals
6/30/2025$ 0
3/31/2025$ 0
12/31/2024$ 0
9/30/2024$ 0
6/30/2024$ 0
3/31/2024$ 0
12/31/2023$ 0
9/30/2023$ 0
6/30/2023$ 0
3/31/2023$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NIAGEN BIOSCIENCE INC's latest trailing twelve months (TTM) CF - Investments stands at $ 0.
  • Over the past 5 years, NIAGEN BIOSCIENCE INC's average CF - Investments has been $ 0.
  • The median CF - Investments for NIAGEN BIOSCIENCE INC during this period was $ 0
  • NIAGEN BIOSCIENCE INC reached its highest CF - Investments over the past 5 years at $ 0.
  • The lowest CF - Investments recorded by NIAGEN BIOSCIENCE INC in the same timeframe $ 0

NIAGEN BIOSCIENCE INC's CF - Investments vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Investments Benchmarks
CompanyCF - Investments
CRMD : CORMEDIX INC $ -14.34MPHAT : PHATHOM PHARMACEUTICALS INC $ 0GYRE : GYRE THERAPEUTICS INC $ -3.08MANAB : ANAPTYSBIO INC $ 80.85MZYME : ZYMEWORKS INC $ 89.51MURGN : UROGEN PHARMA LTD $ -43.29MNRIX : NURIX THERAPEUTICS INC $ 17.67MTBPH : THERAVANCE BIOPHARMA INC $ -7.1MSNDX : SYNDAX PHARMACEUTICALS INC $ -46.1MXNCR : XENCOR INC $ -45.43M

Definition of Net Cash Flow - Investment Acquisitions and Disposals

[Cash Flow Statement] A component of cash flow from investing [NCFI], representing the cash inflow (outflow) from disposal (acquisition) of investments. Includes marketable securities and loan originations.

NAGE - Net Cash Flow - Investment Acquisitions and Disposals, Last 5 years

$ 0

Minimum

Sep 30, 2020

$ 0

Maximum

Sep 30, 2020

$ 0

Average

$ 0

Median

CF - Investments Benchmark Analysis

The chart above depicts the distribution of CF - Investments for companies in the Total Stock Market. The average CF - Investments of the companies is $ 36.68K with a standard deviation of $ 2.27M.
The following table provides additional summary stats:
CF - Investments in the Market:
filtered constituents2.5K
min$ -9.71M
max$ 9.69M
average$ 36.68K
median$ 0
std$ 2.27M